Valuation Astellas Pharma Inc. OTC Markets

Stocks

Market Closed - OTC Markets 06:59:40 16/10/26 am AEDT			5-day change	1st Jan Change
14.91 ^USD	+3.90%		+5.00%	+12.19%

09/10	Vir Biotechnology's VIR-5500 Gets FDA Fast Track Designation for Prostate Cancer	MT
08/10	Vir Biotechnology, Inc. and Astellas Pharma Inc. Announce FDAFast Track Designation for PSMA-Targeted Pro-XTEN® Dual-Masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	3,519,738	3,381,409	2,946,773	2,589,390	4,512,563	4,225,237	-	-
Change	-	-3.93%	-12.85%	-12.13%	74.27%	-6.37%	-	-
Enterprise Value (EV) ¹	3,203,752	3,004,569	2,611,086	3,232,444	4,796,910	4,166,058	3,744,583	3,369,295
Change	-	-6.22%	-13.1%	23.8%	48.4%	-13.15%	-10.12%	-10.02%
P/E	28.5x	34.7x	173x	51x	15.5x	10.8x	11.6x	15.1x
PBR	2.39x	2.24x	1.85x	1.71x	2.47x	2.02x	1.83x	1.74x
PEG	-	-1.8x	-2.1x	0x	0x	0.3x	-1.53x	-0.7x
Capitalization / Revenue	2.72x	2.23x	1.84x	1.35x	2.11x	1.78x	1.91x	2.14x
EV / Revenue	2.47x	1.98x	1.63x	1.69x	2.24x	1.76x	1.69x	1.71x
EV / EBITDA	13.6x	12.6x	14.2x	13.5x	8.31x	5.49x	5.29x	5.59x
EV / EBIT	20.6x	22.6x	102x	78.8x	12.5x	8.19x	7.86x	9.1x
EV / FCF	14.1x	10.3x	-3.88x	20.5x	9.72x	9x	6.81x	6.53x
FCF Yield	7.08%	9.7%	-25.8%	4.87%	10.3%	11.1%	14.7%	15.3%
Dividend per Share ²	50	60	70	74	78	80.15	83.08	85.31
Rate of return	2.62%	3.19%	4.26%	5.12%	3.1%	3.4%	3.53%	3.62%
EPS ²	67.08	54.24	9.51	28.35	162.8	219	202.4	155.9
Distribution rate	74.5%	111%	736%	261%	47.9%	36.6%	41%	54.7%
Net sales ¹	1,296,163	1,518,619	1,603,672	1,912,323	2,139,245	2,371,429	2,209,470	1,970,501
EBITDA ¹	235,370	238,767	183,358	240,171	577,227	759,330	707,826	602,722
EBIT ¹	155,686	133,029	25,518	41,039	382,633	508,934	476,158	370,335
Net income ¹	124,086	98,714	17,045	50,747	291,535	376,912	345,056	262,291
Net Debt ¹	-315,986	-376,840	-335,687	643,054	284,347	-59,179	-480,654	-855,942
Reference price ²	1,911.00	1,883.00	1,643.50	1,446.50	2,519.00	2,356.50	2,356.50	2,356.50
Nbr of stocks (in thousands)	1,841,831	1,795,756	1,792,986	1,790,107	1,791,411	1,793,014	-	-
Announcement Date	27/4/22	27/4/23	25/4/24	25/4/25	27/4/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.8x	12.9x	27.02x	0.55%	1,116B
JOHNSON & JOHNSON	37.07x	6.25x	17.38x	2.11%	610B
ABBVIE INC.	36.17x	8.31x	17.13x	2.45%	501B
MERCK & CO., INC.	112.15x	5.92x	25.35x	2.35%	358B
ROCHE HOLDING AG	20.49x	5x	12.4x	2.64%	366B
NOVARTIS AG	21.24x	5.55x	13.66x	2.88%	288B
ASTRAZENECA PLC	22x	4.43x	12.71x	1.99%	261B
AMGEN INC.	27.56x	7.08x	12.68x	2.32%	235B
GILEAD SCIENCES, INC.	-45.98x	7.04x	27.26x	2.1%	195B
Average	29.61x	6.94x	18.40x	2.15%	436.64B
Weighted average by Cap.	35.04x	8.17x	19.98x	1.84%